It is used to treat various respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, and pneumonia. The global oxygen therapy market is estimated to be valued at USD 34.5 billion in 2022 and is expected to exhibit a CAGR of 6.51% over the forecast period 2023-2030, according to a new report published by Coherent Market Insights.
A) Market Overview:
The global oxygen therapy market is experiencing significant growth due to several factors. The increasing prevalence of respiratory disorders worldwide, coupled with the rising geriatric population, is driving the demand for oxygen therapy. Additionally, technological advancements in oxygen delivery devices, such as portable concentrators, are making oxygen therapy more accessible and convenient for patients. However, high costs associated with oxygen therapy equipment and strict regulatory requirements may hinder market growth.
B) Market Key Trends:
One of the key trends in the oxygen therapy market is the increasing adoption of portable oxygen concentrators (POCs). POCs are lightweight, battery-operated devices that allow patients to receive oxygen therapy while on the go. They offer greater mobility and freedom compared to traditional oxygen tanks, which require refilling and limit patients’ movement. For example, Inogen, a key player in the market, offers Inogen One G4, a portable oxygen concentrator that provides continuous flow oxygen therapy in a compact and lightweight design.
C) Segment Analysis:
The oxygen therapy market is segmented based on product type, end-user, and geography. The product type segment includes oxygen source equipment, oxygen delivery devices, and accessories. Among these, the oxygen delivery devices segment is dominating the market, owing to the increasing demand for devices such as nasal cannulas, masks, and venturi masks for delivering oxygen to patients. These devices are widely used in hospitals, long-term care facilities, and home healthcare settings.
D) Key Takeaways:
– Market Size: The global Oxygen Therapy Market is expected to witness high growth, exhibiting a CAGR of 6.51% over the forecast period. The increasing prevalence of respiratory disorders and technological advancements in oxygen delivery devices are driving market growth.
– Regional Analysis: North America is the fastest-growing and dominating region in the oxygen therapy market. The presence of well-established healthcare infrastructure, high healthcare expenditure, and a large patient population contribute to the region’s market dominance.
– Key Players: Key players operating in the global oxygen therapy market include Respironics, Inc. (a Philips company), Fisher & Paykel Healthcare Limited, Teleflex Incorporated, Invacare Corporation, AirSep Corporation, CareFusion Corporation, DeVilbiss Healthcare, MAQUET Holding B.V. & Co. KG, and ResMed, Inc.. These companies focus on strategic collaborations and product innovations to maintain their market position.
The global oxygen therapy market is witnessing significant growth due to the increasing prevalence of respiratory disorders and advancements in oxygen delivery devices. The adoption of portable oxygen concentrators is a key trend in the market. The oxygen delivery devices segment is dominating the market, driven by the demand for devices such as nasal cannulas and masks. North America is the fastest-growing and dominating region in the market, and key players are focusing on collaborations and product innovations to stay competitive.
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals.